Form 8-K - Current report:
SEC Accession No. 0001104659-13-020704
Filing Date
2013-03-14
Accepted
2013-03-14 17:29:20
Documents
4
Period of Report
2013-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-2746_78k.htm 8-K 31492
2 EX-10.1 a13-2746_7ex10d1.htm EX-10.1 496928
3 EX-10.2 a13-2746_7ex10d2.htm EX-10.2 152055
4 EX-99.1 a13-2746_7ex99d1.htm EX-99.1 7986
  Complete submission text file 0001104659-13-020704.txt   689672
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-902-0682
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54647 | Film No.: 13691423
SIC: 2834 Pharmaceutical Preparations